Prognostic value of baseline circulating tumor DNA (ctDNA) tumor fraction (TF) in metastatic hormone-sensitive prostate cancer (mHSPC)

被引：0
作者：
Nguyen, Charles B.
Tsung, Irene
Lee, Jessica K.
Pasquina, Lincoln W.
Kasputis, Amy
Lovett, Jennie L.
Graf, Ryon P.
Cackowski, Frank Cameron
Heath, Elisabeth I.
Morgan, Todd Matthew
Reichert, Zachery R.
机构：
[1] Univ Michigan, Rogel Comprehens Canc Ctr, Ann Arbor, MI 48109 USA
[2] Fdn Med Inc, Cambridge, MA USA
[3] Fdn Med Inc, San Diego, CA USA
[4] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5085
引用
收藏
页数：1
相关论文
共 50 条
[11]   DISEASE BURDEN OF METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) IN CHINA [J].
Yu, M. ;
Duan, X. ;
Wang, J. ;
Zhang, X. J. ;
Yu, F. .
VALUE IN HEALTH, 2021, 24 :S39-S40
[12]   Recent developments in the treatment of metastatic hormone-sensitive prostate cancer (mHSPC) [J].
Schwentner, Christian .
AKTUELLE UROLOGIE, 2022, 53 (01) :31-36
[13]   Prognostic value of circulating tumor DNA fraction (TF) for patients with metastatic renal cell carcinoma (mRCC). [J].
Zurita, Amado J. ;
Danziger, Natalie ;
Scott, Takara ;
Gjoerup, Ole ;
Zhong, Lei ;
Tukachinsky, Hanna ;
Ross, Jeffrey S. ;
Graf, Ryon .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) :455-455
[14]   Circulating Tumor Cell Count and Overall Survival in Patients With Metastatic Hormone-Sensitive Prostate Cancer [J].
Goldkorn, Amir ;
Tangen, Catherine ;
Plets, Melissa ;
Bsteh, Daniel ;
Xu, Tong ;
Pinski, Jacek K. ;
Ingles, Sue ;
Triche, Timothy Junius ;
Macvicar, Gary R. ;
Vaena, Daniel A. ;
Crispino, Anthony W. ;
Mcconkey, David James ;
Lara, Primo N. ;
Hussain, Maha H. A. ;
Quinn, David I. ;
Dorff, Tanya B. ;
Lerner, Seth Paul ;
Thompson, Ian ;
Agarwal, Neeraj .
JAMA NETWORK OPEN, 2024, 7 (10) :e2437871
[15]   Relationship of circulating tumor DNA (ctDNA) tumor fraction with prognosis in patients with metastatic pancreatobiliary cancer [J].
Pathak, Priyadarshini ;
Li, Gerald ;
Quintanilha, Julia ;
Keller-Evans, Rachel B. ;
Pasquina, Lincoln W. ;
Thierauf, Julia ;
Elvin, Julia A. ;
Ross, Jeffrey S. ;
Graf, Ryon P. ;
Parikh, Aparna Raj ;
Pishvaian, Michael J. .
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL)
[16]   Relationship of tumor fraction in circulating tumor DNA (ctDNA) with prognosis in patients with metastatic pancreatic cancer [J].
Pathak, Priyadarshini ;
Li, Gerald ;
Quintanilha, Julia ;
Keller, Rachel Beth ;
Pasquina, Lincoln ;
Thierauf, Julia ;
Graf, Ryon ;
Parikh, Aparna Raj ;
Pishvaian, Michael J. .
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) :621-621
[17]   ANALYSIS OF THE PROGNOSTIC SIGNIFICANCE OF CIRCULATING TUMOR DNA (CTDNA) IN METASTATIC CASTRATE RESISTANT PROSTATE CANCER (MCRPC) [J].
Shaya, Justin ;
Randall, J. Michael ;
Millard, Frederick ;
Kurzrock, Razelle ;
Parsons, J. Kellogg ;
Tamayo, Pablo ;
McKay, Rana .
JOURNAL OF UROLOGY, 2020, 203 :E1094-E1095
[18]   IDENTIFYING AND CHARACTERIZING METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) POPULATION IN FINLAND [J].
Ruotsalainen, J. ;
Korhonen, M. J. ;
Purmonen, T. ;
Joutseno, J. ;
Saavuori, N. .
VALUE IN HEALTH, 2023, 26 (12) :S535-S535
[19]   Management of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): an Evolving Treatment Paradigm [J].
Weiner, Adam B. ;
Nettey, Oluwarotimi S. ;
Morgans, Alicia K. .
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (09)
[20]   AR-V7 expression in circulating tumor cells as a potential prognostic marker in metastatic hormone-sensitive prostate cancer [J].
Josefsson, Andreas ;
Damber, Jan-Erik ;
Welen, Karin .
ACTA ONCOLOGICA, 2019, 58 (11) :1660-1664
12345